Enhanced	O
Identification	O
of	O
Transcriptional	O
Enhancers	O
Provides	O
Mechanistic	O
Insights	O
into	O
Diseases	O
.	O


Enhancers	O
are	O
distal	O
cis	O
-	O
regulatory	O
DNA	O
elements	O
that	O
increase	O
the	O
expression	O
of	O
target	O
genes	O
.	O


Various	O
experimental	O
and	O
computational	O
approaches	O
including	O
chromatin	O
signature	O
profiling	O
have	O
been	O
developed	O
to	O
predict	O
enhancers	O
on	O
a	O
genome	O
-	O
wide	O
scale	O
,	O
although	O
each	O
method	O
has	O
its	O
advantages	O
and	O
disadvantages	O
.	O


Here	O
we	O
overview	O
an	O
emerging	O
method	O
to	O
identify	O
transcribed	O
enhancers	O
at	O
exceedingly	O
high	O
nucleotide	O
resolution	O
based	O
on	O
enhancer	O
RNA	O
transcripts	O
captured	O
by	O
Cap	O
Analysis	O
of	O
Gene	O
Expression	O
(	O
CAGE	O
)	O
technology	O
.	O


We	O
further	O
argue	O
that	O
disease	O
-	O
causative	O
regulatory	O
mutations	O
at	O
enhancers	O
are	O
increasingly	O
recognized	O
,	O
emphasizing	O
the	O
importance	O
of	O
enhancer	O
identification	O
in	O
functional	O
and	O
clinical	O
genomics	O
including	O
,	O
but	O
not	O
limited	O
to	O
,	O
genome	O
-	O
wide	O
association	O
studies	O
(	O
GWASs	O
)	O
and	O
cancer	S-DISEASE
genomics	O
studies	O
.	O
